Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at a new way of having radiotherapy to the brain (HIPPO)

Overview

Cancer types:

Brain (and spinal cord) tumours

Status:

Closed

Phase:

Phase 2

Details

This trial is looking at whole brain radiotherapy that avoids the hippocampus for people with cancer that has spread to the brain. The hippocampus is the area of the brain which is mainly to do with memory, particularly short term memory. You have 2 hippocampi, 1 on the left and 1 on the right side of your brain.

It is for people with any type of cancer apart from:

  • small cell cancers (such )

  • blood cancers such as leukaemia, or lymphoma

  • cancer that started in the brain (primary brain tumours) or the (central nervous system)

Cancer Research UK supports this trial.

Recruitment start: 12 April 2016

Recruitment end: 24 January 2018

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Gillian Whitfield

Supported by

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

Manchester Academic Heath Science Centre

National Cancer Research Institute (NCRI)

The Brain Tumour Charity

University College London (UCL)

Other information

This is Cancer Research UK trial number CRUK/13/017.

Last reviewed: 24 January 2018

CRUK internal database number: 11735

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.